The ERBB3 receptor in cancer and cancer gene therapy

G Sithanandam, LM Anderson - Cancer gene therapy, 2008 - nature.com
ERBB3, a member of the epidermal growth factor receptor (EGFR) family, is unique in that its
tyrosine kinase domain is functionally defective. It is activated by neuregulins, by other …

The hamster model of sequential oral oncogenesis

E Vairaktaris, S Spyridonidou, V Papakosta, A Vylliotis… - Oral oncology, 2008 - Elsevier
Oral squamous cell carcinoma (OSCC) is a common cancer characterised by low survival
rate and poor prognosis. The multistep process of oral carcinogenesis is affected by multiple …

Prognostic implications of altered human epidermal growth factor receptors (HERs) in gastric carcinomas: HER2 and HER3 are predictors of poor outcome

MD Begnami, E Fukuda, JHTG Fregnani… - Journal of clinical …, 2011 - ascopubs.org
Purpose The human epidermal growth factor receptor (HER) family consists of four
members: ErbB-1 (HER1), ErbB-2 (HER2), ErbB-3 (HER3), and ErbB-4 (HER4). These …

ErbB-3 predicts survival in ovarian cancer

B Tanner, D Hasenclever, K Stern… - Journal of clinical …, 2006 - ascopubs.org
Background HER3 (erbB-3) is a member of the epidermal growth factor receptor (EGFR)
family. After dimerization with other members of the EGFR family several signal transduction …

High expression of HER3 is associated with a decreased survival in gastric cancer

M Hayashi, M Inokuchi, Y Takagi, H Yamada… - Clinical Cancer …, 2008 - AACR
Background: The role of human epidermal growth factor receptor (HER) 3 and HER4 has
been elucidated in gastric cancer. HER1 and HER2 overexpression are regarded as …

Emerging drugs to treat squamous cell carcinomas of the head and neck

C Fung, JR Grandis - Expert opinion on emerging drugs, 2010 - Taylor & Francis
Importance of the field: Head and neck squamous cell carcinoma (HNSCC) is the eighth
leading cause of cancer death worldwide. Despite advances in surgery and chemoradiation …

EGFR enhances the stemness and progression of oral cancer through inhibiting autophagic degradation of SOX2

XX Lv, XY Zheng, JJ Yu, HR Ma, C Hua… - Cancer …, 2020 - Wiley Online Library
Epidermal growth factor receptor (EGFR) is highly expressed in head and neck squamous
cell carcinoma (HNSCC) and correlates with poor prognosis. EGFR has been demonstrated …

Targeting epidermal growth factor receptor and SRC pathways in head and neck cancer

AM Egloff, JR Grandis - Seminars in oncology, 2008 - Elsevier
Epidermal growth factor receptor (EGFR), a member of the ErbB family of receptor tyrosine
kinases (RTKs), is highly expressed in head and neck squamous cell carcinoma (HNSCC) …

The relation between survival and expression of HER1 and HER2 depends on the expression of HER3 and HER4: a study in bladder cancer patients

AA Memon, BS Sorensen, P Meldgaard… - British journal of …, 2006 - nature.com
Increased expression of the epidermal growth factor (EGF) receptors, HER1 and HER2 are
related to poor prognosis in most cancers studied. Recently, a high expression of the two …

Prognostic and Clinicopathological Significance of Epidermal Growth Factor Receptor (EGFR) Expression in Oral Squamous Cell Carcinoma: Systematic Review and …

JL Cívico-Ortega, I González-Ruiz… - International Journal of …, 2023 - mdpi.com
The aim of this systematic review and meta-analysis was to evaluate the current evidence in
relation to the clinicopathological and prognostic significance of epidermal growth factor …